Does Dronedarone Interact with Rapamycin?
Dronedarone and Rapamycin have a moderate drug interaction according to U.S. FDA drug labeling data. Monitor and adjust dosage as needed. Dronedarone is a CYP3A and P-gp inhibitor that increases exposure of narrow therapeutic index substrates. The mechanism involves cyp3a and p-glycoprotein inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Dronedarone Class
- Antiarrhythmic
- Rapamycin Class
- mTOR Inhibitor Immunosuppressant
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Dronedarone and Rapamycin occurs because cyp3a and p-glycoprotein inhibition. Clinically, this means monitor and adjust dosage as needed. dronedarone is a cyp3a and p-gp inhibitor that increases exposure of narrow therapeutic index substrates. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Dronedarone and your doctor is considering prescribing Rapamycin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider